Ruvandhi Nathavitharana
Track Director · Beth Israel Deaconess Medical Center
Credentials: ·
History
Research
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
JAMA · 2021 · 243 citations
European Respiratory Journal · 2016 · 236 citations
The Tuberculosis Cascade of Care in India's Public Sector: A Systematic Review and Meta-analysis
Systematic review or meta-analysis · PLoS Medicine · 2016 · 199 citations
19 papers
- CD
11 papers
10 papers · 7 as a fellow
- PL
10 papers
- DT
8 papers
- RS
5 papers
4 papers
4 papers
Grants
- 2023–2028
THWART-TB : Testing Health Workers At Risk to Advance Our Understanding of TB Infection
National Institute of Allergy and Infectious Diseases · DP2
Contact PI · $1.6M · Beth Israel Deaconess Medical Center
- 2018–2024
Optimizing Diagnostic Strategies for TB Transmission Control in Health-Care Facilities
National Institute of Allergy and Infectious Diseases · K23
Contact PI · $945K · Beth Israel Deaconess Medical Center
Clinical trials
- 2024–2029
Testing Health Workers At Risk to Advance Our Understanding of TB Infection
Principal investigator · Recruiting
Beth Israel Deaconess Medical Center